Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Moderna Beat Novavax to Market With a COVID-Flu Vaccine?

TheMotleyFool

0 0

Could Moderna Beat Novavax to Market With a COVID-Flu Vaccine?

Combination vaccines could enjoy significant demand if COVID-19 becomes endemic, as many expect. In this Motley Fool Live video recorded on Jan. 19, Motley Fool contributors Keith Speights and Brian Orelli discuss whether Moderna (NASDAQ: MRNA) could beat Novavax (NASDAQ: NVAX) with a combo COVID-flu vaccine.

Source Fool.com

Like: 0

MRNA

Share